These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24024471)

  • 1. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
    Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
    Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
    Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
    Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
    Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
    Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.
    Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon YD; Harsum S; MacLaren RE; Charteris DG; Van Meurs JC; González-Sarmiento R; Pastor JC;
    Acta Ophthalmol; 2015 Nov; 93(7):e541-9. PubMed ID: 25991504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
    Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
    Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
    Tawfeek GA; Alhassanin S
    Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia.
    Fernandes AT; Rocha NP; Vendrame E; Russomano F; Grinsztejn BJ; Friedman RK; Pinto AC; Klumb EM; Avvad E; Macedo J; Martínez-Maza O; Bonecini-Almeida Mda G
    Apoptosis; 2015 Oct; 20(10):1347-57. PubMed ID: 26272263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility.
    Zhang N; Li X; Tao K; Jiang L; Ma T; Yan S; Yuan C; Moran MS; Liang F; Haffty BG; Yang Q
    BMC Med Genet; 2011 Apr; 12():48. PubMed ID: 21457555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of
    Al-Zubaidy HFS; Majeed SR; Al-Koofee DAF
    Arch Razi Inst; 2022 Apr; 77(2):799-808. PubMed ID: 36284943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study Investigating the Role of 2 Candidate SNPs in Bax and Bcl-2 Genes in Alzheimer's Disease.
    Erdal ME; Görücü Yilmaz S; Ay ME; Güler Kara H; Avci Özge A; Tasdelen B
    P R Health Sci J; 2020 Sep; 39(3):264-269. PubMed ID: 33031695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.
    Moschos MM; Chatziralli I; Brouzas D; Gazouli M
    Ophthalmic Res; 2017; 58(4):227-230. PubMed ID: 28877516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; Cintra ML; Moraes AM; Lima CS
    J Dermatol Sci; 2014 May; 74(2):135-41. PubMed ID: 24461648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
    Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
    Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
    Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.